Latest Breaking News On - Lupin group - Page 1 : comparemela.com
88academics India raises $3 mn funding from Aarin Capital Partners, others
mybigplunge.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mybigplunge.com Daily Mail and Mail on Sunday newspapers.
Tilray, Inc. (TLRY) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble.
Tilray, Inc. (NASDAQ: TLRY)
Thank you. You may begin, sir.
Raphael Gross
Investor Relations
Good afternoon and thank you for joining us on Tilray s 2020 full fiscal year and fourth-quarter earnings conference call and Webcast. On with me today are Brendan Kennedy, chief executive officer; and Michael Kruteck, chief financial officer. Before we begin, please remember that during the course of our discussion, management may make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as amended. These statements are based on management s current expectations and beliefs that may prove to be incorrect and involve known and unknown risks and uncertainties.
Share:
PALM BEACH, Fla., Dec. 14, 2020 /PRNewswire/ In recent years, cannabis and products with cannabis components, such as CBD, are one of the hot topics in the life sciences industry. Many countries now allow the medical use of cannabis to treat numerous conditions, including chronic pain, cancer, multiple sclerosis, and many others. Additionally, more and more countries have recently allowed the recreational use of cannabis. Finally, hemp (cannabis grown without mind-altering substances), is another burgeoning industry worldwide. Though there are international treaties in place, the production, distribution, and consumption of controlled substances (including cannabis) are still traditionally regulated by each country individually (even within the EU). Some countries still consider cannabis a dangerous illicit substance. Thus the legal landscape on cannabis and cannabis products is very fragmented and complicated, making it hard to get involved in the cannabis industry. Alph
Palm Beach, FL – December 14, 2020 – In recent years, cannabis and products with cannabis components, such as CBD, are one of the “hot topics” in the life sciences industry. Many countries now allow the medical use of cannabis to treat numerous conditions, including chronic pain, cancer, multiple sclerosis, and many others. Additionally, more and more countries have recently allowed the recreational use of cannabis. Finally, hemp (cannabis grown without mind-altering substances), is another burgeoning industry worldwide. Though there are international treaties in place, the production, distribution, and consumption of controlled substances (including cannabis) are still traditionally regulated by each country individually (even within the EU). Some countries still consider cannabis a dangerous illicit substance. Thus the legal landscape on cannabis and cannabis products is very fragmented and complicated, making it hard to get involved in the cannabis industry. Alpha Green Re
vimarsana © 2020. All Rights Reserved.